Cite
HARVARD Citation
Chughlay, M. et al. (2020). First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. British journal of clinical pharmacology. 86 (6), pp. 1113-1124. [Online].